Can G-quadruplex become a promising target in HBV therapy?
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1091873
Abstract: The chronic infection with hepatitis B virus (HBV) is an important health problem that affects millions of people worldwide. Current therapies for HBV always suffer from a poor response rate, common side effects, and the… read more here.
Keywords: hbv; become promising; promising target; therapy ... See more keywords